Cytokinetics Inc (CYTK)

Nov 18, 2024

H.C. Wainwright keeps Buy rating on Cytokinetics shares, citing promising data on aficamten and omecamtiv - Investing.com Canada

Nov 18, 2024

Nov 18, 2024

Cytokinetics' (CYTK) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 18, 2024

Nov 16, 2024

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024 - Yahoo Finance

Nov 16, 2024

Nov 16, 2024

Principal Financial Group Inc. Sells 120,497 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) - MarketBeat

Nov 16, 2024

Nov 15, 2024

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024 - Marketscreener.com

Nov 15, 2024

Nov 14, 2024

Significant Portfolio Addition: T. Rowe Price Investment Managem - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Insider Sale at Cytokinetics Inc (CYTK): EVP Research & Developm - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Cytokinetics: On The Cusp Of Commercialization (NASDAQ:CYTK) - Seeking Alpha

Nov 14, 2024

Nov 13, 2024

Cytokinetics EVP sells $370,880 in stock By Investing.com - Investing.com Nigeria

Nov 13, 2024

Nov 13, 2024

Cytokinetics EVP sells $370,880 in stock - Investing.com

Nov 13, 2024

Nov 13, 2024

Cytokinetics' SWOT analysis: cardiac drug maker's stock poised for growth - Investing.com

Nov 13, 2024

Nov 13, 2024

Cytokinetics, Incorporated (NASDAQ:CYTK) Receives $83.67 Average Price Target from Brokerages - MarketBeat

Nov 13, 2024

Nov 12, 2024

FMR LLC Bolsters Stake in Cytokinetics Inc - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Cytokinetics to Present at Jefferies London Healthcare Conference 2024 | CYTK Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

Lisanti Capital Growth LLC Sells 26,800 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) - MarketBeat

Nov 12, 2024

Nov 11, 2024

Cytokinetics Launches Phase 1 Trial for Novel Muscle Function Drug CK-089 | CYTK Stock News - StockTitan

Nov 11, 2024

Nov 11, 2024

HC Wainwright Forecasts Reduced Earnings for Cytokinetics - MarketBeat

Nov 11, 2024

Nov 11, 2024

Cytokinetics, Incorporated Announces Initiation of Phase 1 Clinical Study of CK-4015089 - Marketscreener.com

Nov 11, 2024

Nov 10, 2024

Van ECK Associates Corp Has $3.80 Million Stock Holdings in Cytokinetics, Incorporated (NASDAQ:CYTK) - MarketBeat

Nov 10, 2024

Nov 08, 2024

Cytokinetics started at outperform by RBC, valuation cited - MSN

Nov 08, 2024

Nov 08, 2024

Eyeing drug launch in 2025, Cytokinetics rolls out HCM awareness campaign - MM+M Online

Nov 08, 2024

Nov 08, 2024

This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Nov 08, 2024

Nov 08, 2024

Cytokinetics (NASDAQ:CYTK) Now Covered by Analysts at Royal Bank of Canada - MarketBeat

Nov 08, 2024

Nov 08, 2024

Cytokinetics, Incorporated (NASDAQ:CYTK) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

Nov 08, 2024

Cytokinetics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 08, 2024

Nov 07, 2024

Cytokinetics: Q3 Earnings Snapshot - AOL

Nov 07, 2024

Nov 07, 2024

Cytokinetics director resigns, board reduced to eight By Investing.com - Investing.com UK

Nov 07, 2024

Nov 07, 2024

Cytokinetics (NASDAQ:CYTK) Posts Earnings Results, Misses Estimates By $0.09 EPS - MarketBeat

Nov 07, 2024

Nov 07, 2024

Cytokinetics Inc (CYTK) Q3 2024 Earnings Call Highlights: Strate - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Cytokinetics Inc (CYTK) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ... - Yahoo Finance

Nov 07, 2024

Nov 06, 2024

Cytokinetics Inc earnings missed by $0.13, revenue fell short of estimates - Investing.com Canada

Nov 06, 2024

Nov 06, 2024

Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 06, 2024

Nov 06, 2024

Cytokinetics Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 06, 2024

Nov 06, 2024

International Assets Investment Management LLC Takes Position in Cytokinetics, Incorporated (NASDAQ:CYTK) - MarketBeat

Nov 06, 2024

Nov 05, 2024

Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024 - The Manila Times

Nov 05, 2024

Nov 05, 2024

Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific ... - NRToday.com

Nov 05, 2024

Nov 05, 2024

Earnings To Watch: Cytokinetics Inc (CYTK) Reports Q3 2024 Resul - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

Earnings To Watch: Cytokinetics Inc (CYTK) Reports Q3 2024 Result - Yahoo Finance

Nov 05, 2024

Nov 05, 2024

AlphaCentric Advisors LLC Takes Position in Cytokinetics, Incorporated (NASDAQ:CYTK) - MarketBeat

Nov 05, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition of Cytokinetics Inc S - GuruFocus.com

Nov 05, 2024

Nov 04, 2024

Robert I. Blum Sells 5,000 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) Stock - MarketBeat

Nov 04, 2024

Nov 04, 2024

Cytokinetics CEO Robert Blum sells $258,150 in stock - Investing.com

Nov 04, 2024

Nov 04, 2024

Cytokinetics CEO Robert Blum sells $258,150 in stock By Investing.com - Investing.com Australia

Nov 04, 2024

Nov 04, 2024

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - XM

Nov 04, 2024

Nov 04, 2024

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Nov 04, 2024

Nov 01, 2024

Cytokinetics director Wendall Wierenga sells shares worth $232,617 By Investing.com - Investing.com South Africa

Nov 01, 2024

Nov 01, 2024

abrdn plc Trims Stock Holdings in Cytokinetics, Incorporated (NASDAQ:CYTK) - MarketBeat

Nov 01, 2024

Oct 31, 2024

Cytokinetics EVP Malik Fady Ibraham sells $378,930 in stock By Investing.com - Investing.com Australia

Oct 31, 2024

Oct 31, 2024

Cytokinetics director Wendall Wierenga sells shares worth $232,617 - Investing.com India

Oct 31, 2024

Oct 31, 2024

Cytokinetics EVP Malik Fady Ibraham sells $378,930 in stock - Investing.com

Oct 31, 2024